Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds

Dallas, TX, March 06, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX), a company focused on developing, marketing, and selling a variety of health and wellness prod...

Early report Major update Updated Mar 6, 2026, 9:00 PM UTC

Track this event Edit in app More event pages

What changed

Early report surfaced from GlobeNewswire Public Companies 4h ago.

First seen Mar 6, 2026, 9:00 PM UTC Latest source Mar 6, 2026, 9:00 PM UTC

Update 1 4h ago

Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds

GlobeNewswire Public Companies •published Mar 6, 2026, 9:00 PM UTC •fetched Mar 6, 2026, 9:11 PM UTC

Event stats

Reports 1

Sources 1

Confidence low

Score 41

Entity focus

MangoceuticalsIncAnnouncesPatentFiling

Source spread

GlobeNewswire Public Companies

Turn this into an alert

Draft the watch from the event wording, then let PushMe handle follow-up changes.

Notify me about major new developments on Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds, espe…

Create alert from this event